Skip to main content

Table 1 Patient’s and volunteer’s characteristics

From: The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study

  All SLE (n = 73) pSS (n = 23) HV (n = 23) p value§
Age, median (IQR) years 43 (34–57) 44 (33–58) 34 (22–49) 0.44
Female sex (%) 65 (89) 21 (91) 20 (87) 0.89
Caucasian, no. (%) 56 (77) 19 (83) 20 (87) 0.53
Higher education*, no./total (%) 30/59 (51) 10/22 (45) 10/23 (43) 0.80
Active smoker, no. (%) 17 (23) 4 (17) 8 (35) 0.37
Body mass index, median (IQR) 23 (20–28) 25 (22–28) 22 (20–24) 0.48
Use of psychiatric medication£, no. (%) 14 (19) 8 (34) 3 (13) 0.16
Time from diagnosis, median (IQR) years 7 (3–15) 1 (0–2) < 0.01
Immunomodulators past month, no. (%) 64 (88) 16 (70) 0.04
 Antimalarials, no. (%) 52 (71) 14 (61) 0.35
 Systemic corticosteroids, no. (%) 39 (53) 5 (22) 0.01
 Immunosuppressants, no (%) 35 (48) 5 (22) 0.03
  1. SLE systemic lupus erythematosus, pSS primary Sjogren syndrome, HV healthy volunteers, IQR interquartile range
  2. *Defined as higher professional or technical school or university degree
  3. £Defined as any antidepressants, antipsychotics, and anxiolytics/hypnotics
  4. §p value < 0.05 is considered significant